• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

增加变应原免疫治疗依从性的方法。

Ways to increase adherence to allergen immunotherapy.

机构信息

a Medical School, University of Cyprus , Nicosia , Cyprus.

出版信息

Curr Med Res Opin. 2019 Jun;35(6):1027-1031. doi: 10.1080/03007995.2018.1552044. Epub 2018 Dec 21.

DOI:10.1080/03007995.2018.1552044
PMID:30468080
Abstract

Adherence to allergen immunotherapy (AIT) is crucial for its efficacy. Subcutaneous AIT requires monthly visits (or more extended in the case of venom immunotherapy), while sublingual AIT is performed with a daily intake of allergen drops. Non-adherence to an AIT schedule and premature discontinuation are common problems. Various studies have shown controversial results on the rate of AIT adherence. The aim of this review is to describe the problem of non-adherence and to offer some evidence-based advice to allergologists on how to increase it. Better patient education at the beginning of treatment, sharing with patients the decision on which type of immunotherapy to select and showing sincere interest in their treatment concerns are some tips that can help to increase adherence. A well organized allergologist time schedule not only increases safety but also offers the possibility of close follow-up and an increase in patient loyalty.

摘要

变应原免疫治疗(AIT)的依从性对于其疗效至关重要。皮下免疫治疗需要每月就诊(在毒液免疫治疗的情况下可能会延长),而舌下免疫治疗则需要每天摄入过敏原滴剂。不遵守 AIT 计划和过早停药是常见的问题。多项研究对 AIT 依从率的结果存在争议。本综述旨在描述不依从的问题,并为过敏学家提供一些循证建议,以提高依从性。在治疗开始时进行更好的患者教育,与患者共同决定选择哪种类型的免疫治疗,并真诚关注他们的治疗问题,这些都是可以帮助提高依从性的建议。合理安排过敏科医生的时间安排不仅可以提高安全性,还可以提供密切随访和增加患者忠诚度的可能性。

相似文献

1
Ways to increase adherence to allergen immunotherapy.增加变应原免疫治疗依从性的方法。
Curr Med Res Opin. 2019 Jun;35(6):1027-1031. doi: 10.1080/03007995.2018.1552044. Epub 2018 Dec 21.
2
Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.皮下和舌下过敏原免疫治疗使用者的实际依从性和持久性。
J Allergy Clin Immunol. 2013 Aug;132(2):353-60.e2. doi: 10.1016/j.jaci.2013.03.013. Epub 2013 May 4.
3
Patient selection for subcutaneous versus sublingual immunotherapy.皮下免疫疗法与舌下免疫疗法的患者选择
Curr Opin Allergy Clin Immunol. 2015 Dec;15(6):588-95. doi: 10.1097/ACI.0000000000000219.
4
Comparing the compliance to a short schedule of subcutaneous immunotherapy and to sublingual immunotherapy during three years of treatment.比较皮下免疫疗法短疗程与舌下免疫疗法在三年治疗期间的依从性。
Eur Ann Allergy Clin Immunol. 2016 Nov;48(6):224-227.
5
Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy.免疫疗法依从性:皮下免疫治疗与舌下免疫治疗的比较。
Int Forum Allergy Rhinol. 2016 May;6(5):460-4. doi: 10.1002/alr.21699. Epub 2015 Dec 31.
6
Lack of Harmonized Adherence Criteria in Allergen Immunotherapy Prevents Comparison of Dosing and Application Strategies: A Scoping Review.缺乏变应原免疫治疗的统一依从性标准会阻碍剂量和应用策略的比较:范围综述。
J Allergy Clin Immunol Pract. 2023 Feb;11(2):439-448.e6. doi: 10.1016/j.jaip.2022.10.005. Epub 2022 Oct 20.
7
Clinical contraindications to allergen immunotherapy: an EAACI position paper.变应原免疫治疗的临床禁忌:EAACI 立场文件。
Allergy. 2015 Aug;70(8):897-909. doi: 10.1111/all.12638. Epub 2015 May 18.
8
Adherence to Sublingual Immunotherapy.舌下免疫治疗的依从性
Curr Allergy Asthma Rep. 2016 Feb;16(2):12. doi: 10.1007/s11882-015-0586-1.
9
Evidence of adherence to allergen-specific immunotherapy.过敏原特异性免疫治疗的依从性证据。
Curr Opin Allergy Clin Immunol. 2009 Dec;9(6):544-8. doi: 10.1097/ACI.0b013e328332b8df.
10
Factors Associated with Adherence to Allergen Specific Subcutaneous Immunotherapy.与变应原特异性皮下免疫疗法依从性相关的因素
Yonsei Med J. 2019 Jun;60(6):570-577. doi: 10.3349/ymj.2019.60.6.570.

引用本文的文献

1
Using mobile technology to increase adherence to sublingual immunotherapy: Real-world study with a new app/web platform AllergyVax®.使用移动技术提高舌下免疫疗法的依从性:一项针对新应用程序/网络平台AllergyVax®的真实世界研究。
World Allergy Organ J. 2025 May 12;18(6):101064. doi: 10.1016/j.waojou.2025.101064. eCollection 2025 Jun.
2
Immunotherapy: Current indications and recommendations in the management of ocular allergy.免疫疗法:眼部过敏管理中的当前适应症及建议
Indian J Ophthalmol. 2025 Apr 1;73(4):526-536. doi: 10.4103/IJO.IJO_2853_23. Epub 2024 Sep 19.
3
Promoting patient-centred care in the management of allergic rhinitis in Asia-Pacific countries.
在亚太国家促进以患者为中心的过敏性鼻炎管理。
World Allergy Organ J. 2024 Aug 22;17(9):100952. doi: 10.1016/j.waojou.2024.100952. eCollection 2024 Sep.
4
Tolerability and Safety of Sublingual Immunotherapy in Patients with Tree Pollen Allergy in Daily Practice-An Open, Prospective, Non-Interventional Study.日常实践中舌下免疫疗法治疗花粉过敏患者的耐受性和安全性——一项开放、前瞻性、非干预性研究
J Clin Med. 2023 Aug 25;12(17):5517. doi: 10.3390/jcm12175517.
5
ARIA Care Pathways 2019: Next-Generation Allergic Rhinitis Care and Allergen Immunotherapy in Malaysia.《2019年ARIA护理路径:马来西亚的下一代过敏性鼻炎护理与变应原免疫疗法》
J Pers Med. 2023 May 15;13(5):835. doi: 10.3390/jpm13050835.
6
Digital health for allergen immunotherapy.用于变应原免疫疗法的数字健康
Allergol Select. 2022 Dec 5;6:293-298. doi: 10.5414/ALX02301E. eCollection 2022.
7
Current treatment strategies for seasonal allergic rhinitis: where are we heading?季节性变应性鼻炎的当前治疗策略:我们正走向何方?
Clin Mol Allergy. 2022 Aug 10;20(1):9. doi: 10.1186/s12948-022-00176-x.
8
Patient's Adherence and Compliance and Quality of Life During/After VIT.维生素免疫疗法期间/之后患者的依从性、顺应性及生活质量
Front Allergy. 2022 Jun 28;3:886054. doi: 10.3389/falgy.2022.886054. eCollection 2022.
9
Allergen Immunotherapy: Biomarkers and Clinical Outcome Measures.变应原免疫疗法:生物标志物与临床结局指标
J Asthma Allergy. 2021 Feb 18;14:141-148. doi: 10.2147/JAA.S267522. eCollection 2021.
10
ARIA 2019 Care Pathways for Allergic Rhinitis in the Kuwait Health Care System.ARIA 2019 年在科威特医疗保健系统中变应性鼻炎的护理路径。
Med Princ Pract. 2021;30(4):320-330. doi: 10.1159/000512493. Epub 2020 Oct 23.